• HOKA growth — CONTESTED (the turbo trigger; the one variable this page is about).
• UGG year-round demand — SETTLED by the record (+13% FY2025, +8.2% FY2026, 59.3% brand gross margin).
• Margin structure — SETTLED within a band (gross margin 51.0% → 57.7% across FY2022–FY2026; FY2027 guided ~56.5%, guided down on freight and input costs — freight and Middle East shipping disruption already cited in the FY2027 margin guide).
• Capital return — SETTLED ($4,679.2M authorization remaining; the FY2027 earnings per share (EPS) guide itself assumes buybacks ≈ 80% of free cash flow; the share count has fallen every year, 161.9M → 136.7M period-end; at $86.58, each $1B repurchased removes ~8.5% of the share count).

The record settles three of the four. The page is about the fourth.

1. HOKA's glide path is the whole debate, and the last print was the slowest. Growth has stepped down every year — +46% → +24% → +15.9% → low-double digits guided — and Q1 FY2027 printed +7.7%, below the guide's own trajectory, explained as shipment timing with the recovery pushed to H2. At 47.7% of revenue there is no offset — Other brands shrank −39% in two years.
2. The U.S. engine stalled while the tariff bill was paid with pricing. Domestic revenue grew +0.2% in FY2026; wholesale is 58.3% of sales and HOKA door counts are undisclosed, so a U.S. wholesale destock cannot be monitored from outside. The FY2026 tariff outcome (~$25M net) was achieved with price increases and timing, and management itself warns the net figure is not the run-rate if tariffs persist: the FY2027 guide assumes a 10% Vietnam rate all year and no refund, while the 20% scenario management itself modeled carried a $185M gross cost. Gross margin already guides down (57.7% → ~56.5%).
3. Insiders voted with their feet. Across two years insiders sold $27.77M against $0.20M bought — ~139×. The chief executive officer (CEO) sold non-plan shares at $175.73 three months into the job and plan shares at $208.34, the window's highest insider price; directors and officers own 0.4%. The company's own FY2025 buyback vintage averaged $149.21 and is deeply underwater, and even the FY2026 vintage at $102.43 is ~15% underwater at $86.58. If earnings shrink toward the priced-in path, the same machine is retiring shares in a shrinking business.

• Answers Bear #1: the priced-in scenario requires the guidance machine to break. FY2025 and FY2026 both beat their initial AND final guides on revenue, gross margin and EPS. The FY2027 guide — revenue $5.86–5.91B (+7–8%), EPS $7.35–$7.50 — was struck after absorbing a ~150 bps (basis points) tariff headwind in Q1 with gross margin still +60 bps YoY.
• Answers Bear #2, concedes the monitoring gap: international +26.8% (FY2026) is the offset engine, and HOKA is deliberately under-distributed — doors rationed on productivity; Caroti, Oct 23, 2025: Sell-throughs are stronger than sell-in. UGG, at $2,751.7M TTM and a 38.2% segment margin, already made the year-round transition. Conceded: door counts are undisclosed, so the wholesale channel cannot be monitored from outside.
• Answers Bear #3, concedes the FY2025 vintage: the FY2025 buyback overpaid ($149.21 average) — conceded. But the record since: no insider sales at all after Feb 13, 2026 through the slide to $77.20; FY2026 bought 10.5M shares at $102.43 with the biggest quarter at the $92.36 trough; $1,602.6M net cash, zero debt, and a $4,679.2M authorization ≈ 40% of market cap — at $86.58, each $1B repurchased removes ~8.5% of the count. If operations merely match the negative bar, the ~+4%/yr shrink compounds per-share value on top.

Deckers Outdoor Corporation (NYSE: DECK), headquartered in Goleta, California, designs and sells premium footwear through two global brands and a third smaller one. HOKA — $2,637.7M of TTM revenue — sells maximal-cushion running and outdoor shoes through run-specialty stores, sporting-goods wholesale, and its own stores and website. UGG ($2,751.7M) sells sheepskin boots and an expanding year-round line of slippers, sandals, and apparel-adjacent footwear. Teva (sandals) is the remainder, sitting inside an “Other brands” segment of $137.8M TTM after Sanuk was sold on Aug 15, 2024 and Koolaburra and AHNU were wound down across FY2025–FY2026. Teva's last disclosed standalone figure is FY2024 revenue of $148.5M — 61% of that year's $241.9M Other brands total; it has not been broken out since, which is why the "no third engine" claim above rests on the segment total, not on a current Teva line.

Products are made by independent manufacturers, primarily in Vietnam and elsewhere in Asia; Deckers owns no factories. Sales split 58.3% wholesale / 41.7% direct-to-consumer (DTC), and 58% U.S. / 42% international. The company has no funded debt, $1,602.6M of cash, and has never paid a dividend — cash comes back to shareholders exclusively through share buybacks.

Chief Executive Officer (CEO) Stefano Caroti has run the company since Aug 1, 2024 — an internal promote who previously ran omni-channel and briefly HOKA itself. He succeeded Dave Powers, who retired cleanly: no executive-chair or consulting role, and he left the board in Sep 2025. The fiscal year ends March 31, so FY2026 is the year ended March 31, 2026, and the most recent reported quarter is Q1 FY2027, ended June 30, 2026.

The rows that decide the thesis ($M except margins and shares)

The full series is the reference table below; the charts between Management and Moat show the same three shapes.

Margin defense, in management's own Q1 FY2027 bridge: full-price/mix +~110 bps while absorbing a ~150 bps tariff headwind, closeouts +~60 bps, FX (foreign exchange) +~40 bps — gross margin still rose +60 bps YoY.

The last four quarters: growth gliding down, margins holding

Each value carries its same-quarter YoY change, colored. Guided for Q2 FY2027 on the Q1 call: revenue ~+5% (≈$1.50B), HOKA high-single digits, UGG mid-single digits, EPS $1.73–$1.78.

The full series — FY22–FY26 + TTM ($M unless noted)

Fiscal years end March 31; TTM is the twelve months ended June 30, 2026. The final column is the FY2026 year-over-year change — the table's one signed-change column.

FY2022 operating cash flow ($172.4M) was a working-capital trough, so FY2022-anchored cash-flow growth rates are flattered; on the clean FY2023 base, free cash flow compounded +34.0%/yr and owner earnings +35.4%/yr to FY2026.

† Split-adjusted arithmetically from the pre-split FY2022 filing (6-for-1 split, Sep 13, 2024). ‡ TTM EPS is the sum of the four filed quarterly EPS figures and TTM diluted shares their simple average — approximations, flagged as such; no model input depends on them.

Deckers carries no funded debt at all. Borrowing capacity is two undrawn revolving facilities: the Primary Credit Facility, $400M at Jun 30, 2026, upsized to $500M and extended to Aug 27, 2031 by the Aug 27, 2026 First Amendment, and a China facility of ≈$43.5M — both $0 drawn. Operating leases of $472.3M are excluded from the enterprise value (EV) bridge per house convention and sized in the Reverse DCF memo; a $3.2M supplier-finance obligation sits in payables and is not debt. Stockholders' equity was $2,301.7M at Jun 30, 2026.

Enterprise value bridge ($M)

Buyback authorization history: $261M (2019) + $750M (2021) + $1,200M (2022) + $2,250M (May 21, 2025) + $3,500M (May 20, 2026), no expiry. $4,679.2M remained at Jul 9, 2026 (≈40% of market cap).

Inverting the price: for the enterprise value of $10,208.2M to be fair at a 10% required return, Deckers' owner earnings — free cash flow minus stock-based compensation — must compound at:

The priced-in bars, by base

The three owner-earnings bases cluster within 0.4 points — there is no distortion to normalize away (SBC is 0.8% of revenue).

Credited bars — credit earned

At a demonstrated 2%/yr net shrink the required TOTAL owner-earnings growth is −4.1%/yr; at 4%/yr, −6.0%/yr. Demonstrated shrink: period-end count −4.5%/yr FY2024→FY2026 and −6.8% in FY2026 alone; diluted count −3.3%/yr FY2022→FY2026.

CAP ≈ 0 years: at +12%, +15% and +20% growth, today's owner earnings capitalized at terminal terms alone — 12.75× = $13.7B — already exceed the entire EV. terminal value (TV) = 41.6% of EV; implied terminal EV/EBIT (earnings before interest and taxes) 10.9×.

What you must believe — mature OE margin → required 10-yr revenue growth

Delivered revenue compounding: +14.8%/yr FY2022→FY2026; FY2027 guided +7–8%.

Sensitivity — reported TTM OE base

Memo: solving on EV incl. operating leases ($10,680.5M) moves the bar to −1.5%/yr. Yields: TTM owner earnings = 10.5% of EV; TTM buybacks $1,230.3M = 10.4% of market cap per year at the current pace.

Concentration, sized against the EV

• Two brands are the company. HOKA $2,637.7M (47.7%) + UGG $2,751.7M (49.8%) = $5,389.5M, 97.5% of revenue. FY2026 segment income: HOKA $911.0M (35.2%), UGG $1,045.3M (38.2%), Other $16.4M — before unallocated enterprise costs of ~$709.8M (HOKA+UGG = 155% of consolidated operating income). Allocated at the consolidated TTM OE margin (19.4%), HOKA ≈ $511M and UGG ≈ $533M of owner earnings.
• Channel and geography: wholesale 58.3% / DTC 41.7%; international 42.0% (+26.8% FY2026) vs domestic +0.2%.
• Tariffs: gross estimates $110–185M (1.1–1.8% of EV), net ~$25M delivered.

Model assumptions: 10% hurdle, 10-year window, 2% terminal growth, terminal OE multiple 12.75× (return on invested capital faded to cost of capital), no exit multiples, no analyst estimates, solves on EV $10,208.2M.

Guidance A−. Zero cuts in 12 quarters; FY2025 and FY2026 both beat their initial and final guides on revenue, gross margin (GM) and EPS. The blemish: FY2026's full-year guide was withheld for two quarters amid tariff uncertainty — an availability gap counted here, with the candor of withholding rather than guessing scored there.

Execution A−. HOKA compounded +30.5%/yr FY2022–FY2026 under a deliberately rationed wholesale-door strategy; UGG was re-accelerated from −2.7% (FY2023) to +13.1% (FY2025) at a 59.3% brand gross margin; consolidated gross margin added 6.7 points (51.0% → 57.7%); inventory fell −4.9% YoY at the seasonal peak; Sanuk was sold and Koolaburra/AHNU exited with no material exit costs. Debits: domestic revenue +0.2% in FY2026, and HOKA's slowest print (+7.7%, Q1 FY2027) still to be explained by the Oct 22 print.

Candor A−. Management withheld the FY2026 guide rather than guide blind, and labeled the $150M tariff figure gross when pressed — Fasching, May 22, 2025: The $150 is a gross number. They called their own Q2 FY2026 favorability tariff timing that would reverse, paired the ~$25M net tariff figure with a “not the run-rate” caveat, and put U.S. consumer pressure on the record — Fasching, Oct 23, 2025: the U.S. consumer is a little bit more pressured. Debits: no investor day in 24 months; HOKA door counts refused.

Capital allocation B+ — two vintages. FY2025: 3.8M shares at a $149.21 average, bought into strength — deeply underwater. FY2026: 10.5M shares at $102.43, the biggest quarter at the trough (3.77M shares at $92.36 in Q3 FY2026); Q1 FY2027 continued (3.26M at $103.79). The board enlarged the authorization twice instead of slowing into the drawdown, and the FY2027 EPS guide assumes buybacks ≈ 80% of free cash flow. Even so, at $86.58 the FY2026 vintage is ~15% underwater — FY2025's vintage is why this is B+, not A−.

Alignment C+ — the Form 4 record. Across Oct 2024–Oct 2026 (143 filings), insiders sold $27.77M against $0.20M bought — ~139×. The only open-market purchase was Board Chair Cindy Davis's $0.20M buy — 1,825 shares at $109.76 on Jun 6, 2025. CEO Caroti sold 15,000 shares non-plan at $175.73 on Nov 19, 2024, three and a half months into the job, and 14,274 more under a plan at $208.34 on Dec 11, 2024 — the window's highest insider price. Former CEO Dave Powers was the largest seller ($9.60M). Directors and officers own 0.4%. Mitigants: zero pledges or prepaid forwards (policy prohibits them); pay is performance-weighted, though quantum is full (Caroti FY2026 comp $11.90M, pay ratio 231:1, say-on-pay ~89.7% at the Sep 2026 meeting, from 92.7%); and no insider sales at all after Feb 13, 2026.

People (Fisher 5): an internal promote (Caroti, omni-channel, briefly HOKA) succeeded a clean retirement — Powers took no executive-chair or consulting role and left the board in Sep 2025; succession was orderly and disclosed a year ahead (8-K, Feb 1, 2024).

Fisher's capstone — integrity, assessed on behavior: candor in words is A− (guides withheld rather than invented, tariff figures labeled gross when pressed); the Form 4 record is the deeds ledger, and it caps this grade at B+ until the buying side of it changes.

1. Runway + successor products — ANSWERED: HOKA broadening categories and international moving toward a stated ~50% ambition (42.0% now, +26.8% FY2026); UGG's year-round franchises are the delivered successor line.
2. Innovation productivity — THIN: Bondi/Clifton franchises must be re-won each cycle; the record shows sell-through strength but no disclosed R&D-effectiveness measure to grade.
3. Go-to-market quality — ANSWERED, with one UNANSWERED sub-item: doors rationed on productivity and sell-through ahead of sell-in; but HOKA wholesale door counts are refused — UNANSWERED, and routed to the Downside Checklist.
4. Margin level + its defense — ANSWERED: gross margin 51.0% → 57.7% (FY2022→FY2026); the defense, in management's own Q1 FY2027 bridge: full-price/mix +~110 bps while absorbing a ~150 bps tariff headwind, closeouts +~60 bps, FX +~40 bps.
5. People — ANSWERED (see Management): orderly internal succession; depth below the CEO is thin in the public record.
6. Industry-peculiar edge — ANSWERED, stated plainly: premium price architecture in two distinct categories; there is no patent, network or switching-cost edge, and the page claims none.

Teva's standalone economics — UNANSWERED: not disclosed after FY2024 (inside Other brands, $146.2M FY2026 and shrinking).

The caveats stand: fashion cycles are fast and HOKA's share is re-won each product cycle; UGG demand is discretionary and season-exposed; Q3 is the peak quarter.

• “Paying for growth the record can't support” — PASS: the price requires decline (−2.1%/yr), not growth.
• “A flattered base doing the arguing (trough-year compounding)” — FLAG, contained: FY2022 was a working-capital trough ($172.4M operating cash flow (OCF)); the page argues from the clean FY2023 base (+35.4%/yr owner earnings) wherever the base matters.

• “Funded debt” — PASS: $0; both revolvers undrawn.
• “Hidden leverage” — PASS: operating leases $472.3M are sized on the page and bridged as a memo (bar −1.5%/yr including them); supplier finance is $3.2M, a payables item.

Leverage misjudged is Pabrai's own repeated mistake — checked twice here.

• “Insiders selling while the story is told” — FLAG: $27.77M sold vs $0.20M bought (~139×) across two years; the CEO sold non-plan three months into the job and at the window's highest price under a plan. Mitigants on the record: no pledges or prepaid forwards (policy prohibits them) and no insider sales at all after Feb 13, 2026.
• “The buyback overpaying at strength” — FLAG: the FY2025 vintage averaged $149.21 into strength and is deeply underwater; the FY2026 vintage ($102.43, biggest quarter at the $92.36 trough) is the counter-example, and it too is ~15% underwater at $86.58.
• “Pay quantum drifting from delivery” — FLAG: FY2026 cash incentive paid 152–173% of target on delivered beats, but total CEO comp of $11.90M (231:1) is full, and say-on-pay slipped to ~89.7% from 92.7%.

• “Two-brand concentration” — FLAG: 97.5% of revenue; an earnings halving in either brand alone removes ~5% of the EV's entire earnings base; there is no third engine (Other brands fell $241.9M → $146.2M, FY2024→FY2026).
• “Fashion-cycle dependence” — FLAG: HOKA's share is re-won each product cycle; the glide (+46% → +24% → +15.9% → low-double digits guided; last print +7.7%) is this flag's live form — it is Debate #1 and Checkpoint #2.
• “Single-geography manufacturing” — FLAG: production concentrated in Asia, Vietnam principal; management's own 20% tariff scenario was a $185M gross cost (the Dexter Shoes lesson: foreign-competition and sourcing exposure ends moats quietly).

• “Drawdown euphoria — ‘cheap’ feeling self-evident at −29.2% off the high” — FLAG, named: a negative bar is arithmetic, not a margin-of-safety certificate; it is only low if the decline stops there.
• “Brand affection substituting for the print” — PASS, by construction: the decisive test is numeric and dated (Oct 22: HOKA ≥ +8% / ≤ +5%), set before the print.

Three flags are live — insider selling, buyback timing at strength, and the two-brand moat itself. Each is already priced into the debates above or gated by a dated checkpoint; none is unaddressed, and the moat flag is carried in the verdict box's moat line.

1. Q2 FY2027 revenue vs ~+5% guide (≈$1,503M): PASS ≥ $1,490M; FAIL < $1,450M.
2. HOKA Q2 growth vs guided high-single digits: PASS ≥ +8%; FAIL ≤ +5%.
3. UGG Q2 growth vs guided mid-single digits: PASS ≥ +4%; FAIL ≤ +1%.
4. Q2 gross margin: PASS ≥ 56.0%; FAIL < 54.5%.
5. FY2027 guide: PASS = revenue range maintained or raised (≥ $5.86–5.91B) and EPS ≥ $7.35; FAIL = any revenue-range cut or EPS < $7.30.
6. Buybacks + count (Q2 10-Q): PASS ≥ $250M repurchased and period-end shares ≤ 135.5M; FAIL < $150M.
7. Inventory at Sep 30, 2026: PASS ≤ +5% YoY; FAIL > +12% YoY.
8. Tariff language (binary): FAIL signal = any newly quantified FY2027 gross tariff figure above $150M, or an FY2027 gross-margin guide cut citing tariffs.
9. Later: Q3 FY2027 (late Jan 2027) — HOKA must print ≥ low-double digits or the FY2027 guide's H2 shape fails; Q4 FY2027 (May 2027) — the FY2028 guide is scored against the FY2028–30 framework (high-single-digit revenue, low-20s%+ operating margin).

No investor day has been held in 24 months (verified); strategy is communicated only through guidance, and the FY2028–30 framework is scored at these checkpoints instead.

• Tier 1 — filings (all under central index key (CIK) 0000910521): FY2022–FY2026 10-Ks; Q1 FY2026–Q1 FY2027 10-Qs; earnings releases incl. Q4 FY2026 8-K Ex-99.1, May 21, 2026; DEF 14A filed Jul 24, 2026; 143 Form 4 filings; 8-Ks Feb 1, 2024 / Aug 31, 2026 / Sep 15, 2026; IR earnings-date announcement Oct 12, 2026.
• Tier 2 — transcripts, Q2 FY2024–Q1 FY2027: Deckers IR webcast archive / FactSet PDFs; Motley Fool; MarketBeat — located and read from publisher transcripts.
• Figures 1–3: Qualtrim. Price: Yahoo chart API, Oct 15, 2026 close.
• Gaps we could not close: Teva standalone revenue undisclosed after FY2024; China-specific revenue not disclosed; Sanuk sale price undisclosed in any filing (buyer identity from the buyer's own announcement); HOKA wholesale door counts not disclosed; 10b5-1 adoption dates not stated in Form 4 footnotes; FY2022 per-share data split-adjusted arithmetically; Q4 FY2026 cash-flow splits are FY-minus-9M derivations (the Q4 P&L itself is filed).